Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
EMHJ-Eastern Mediterranean Health Journal. 2011; 17 (3): 191-195
en Inglés | IMEMR | ID: emr-158630

RESUMEN

In 2001, the measles immunization schedule in Saudi Arabia was changed to 2 measles, mumps and rubella vaccine doses at 12 months and at 6 years. In this follow-up study we evaluated the seroresponse to the second measles dose before school entry. We recruited 138 children randomly from primary health care centres in Qassinn; 124 children completed the study. Blood samples were collected before and 1 month after giving the second measles dose, before the age of 6 years. There was a statistically significant increase in the geometric mean titre of measles antibody, from 2205 m lU/mL before vaccination to 4723 mlU/mL after [P = 0.0001]. The proportion of children with positive ELISA results increased fro++ 94.2% before vaccination to 99.2% after [P = 0.02], while the proportion with protective level [00 mlU/mL] increased from 97.1% before vaccination to 99.19% after [P= 0.21]. The 2-dose measles immunization schedule can produce optimum protection at school entry if high vaccination coverage is guaranteed


Asunto(s)
Humanos , Masculino , Femenino , Inmunización Secundaria , Esquemas de Inmunización , Instituciones Académicas , Ensayo de Inmunoadsorción Enzimática
2.
EMHJ-Eastern Mediterranean Health Journal. 2010; 16 (10): 1025-1031
en Inglés | IMEMR | ID: emr-158538

RESUMEN

The aim of this study was to analyse results of the pilot screening round for Al-Qassim Screening Mammography Programme and compare with international standards. Analysis was conducted in the central screening office in Prince Faisal Oncology Centre, which coordinates activities of various screening units. Data were collected during the period 1 January 2007 to 30 June 2008. Organizational and functional information was obtained from policy and procedure manuals of the programme. Out of 9812 eligible women, 1766 [18%] participated and data were available for 1628 [16.6%]. The median age of participants was 47 [standard deviation 8.12] years. The low uptake rate [18%] and a high recall rate [31.6%] characterized the pilot screening round. Biopsy rate was 1.5% and cancer detection rate was 0.24%. Many performance indicators in this pilot screening round were not available. Many of the available indicators did not meet international standards


Asunto(s)
Humanos , Femenino , Adulto , Persona de Mediana Edad , Anciano , Tamizaje Masivo , Neoplasias de la Mama/diagnóstico , Detección Precoz del Cáncer , Proyectos Piloto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA